{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:42Z","timestamp":1789148982786,"version":"build-2803163510"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>This case series measured the results of using upadacitinib for moderate or severe cases of epidermolysis bullosa pruriginosa.<\/jats:p>","DOI":"10.1001\/jamadermatol.2024.2787","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T22:28:36Z","timestamp":1724279316000},"page":"1124","source":"Crossref","is-referenced-by-count":6,"title":["Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib"],"prefix":"10.1001","volume":"160","author":[{"given":"Zeqiao","family":"Zhang","sequence":"first","affiliation":[{"name":"Dermatology Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimiao","family":"Lin","sequence":"additional","affiliation":[{"name":"Dermatology Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"dld240015r1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19462","article-title":"Treatment of chronic prurigo with upadacitinib: a case series.","author":"Gil-Lianes","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dld240015r2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jdv.17671","article-title":"Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity.","volume":"36","author":"Darbord","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dld240015r3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaad.2024.01.088","article-title":"Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: a case-control study.","volume":"91","author":"Papanikolaou","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"dld240015r4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jdcr.2021.07.036","article-title":"Epidermolysis bullosa pruriginosa responding to dupilumab.","volume":"16","author":"Clawson","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"10","key":"dld240015r5","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jamadermatol.2021.3174","article-title":"Epidermolysis bullosa pruriginosa treated with baricitinib.","volume":"157","author":"Jiang","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"dld240015r6","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1111\/jdv.18487","article-title":"Epidermolysis bullosa pruriginosa with extensive truncal involvement treated with upadacitinib.","volume":"37","author":"Kim","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2822713\/jamadermatology_zhang_2024_ld_240015_1729089108.77545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:03:22Z","timestamp":1729091002000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2822713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.2787","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}